Find uplifting stories about heroes, innovations, and solutions
3357 results for "bladder cancer"
A new blood test can predict which bladder cancer patients can safely keep their bladder instead of undergoing surgery. In a clinical trial, 80% of patients who avoided immediate surgery remained cancer-free after two years.
A new immunotherapy treatment is helping bladder cancer patients avoid invasive surgery while achieving better survival rates. British researchers found 85% of patients stayed cancer-free after a year using the gentler approach.
Scientists at MIT created a tiny catheter sensor that catches bladder cancer coming back before tumors become visible, giving patients a huge head start on treatment. The device is 180 times more sensitive than current tests and creates a chemical map showing exactly where cancer cells are growing.
Bladder cancer patients now have more treatment options than ever before, thanks to several new therapies approved in recent years. Doctors are working closely with patients to find the best approach for each person's unique situation. #
Patients with muscle-invasive bladder cancer now have the first major treatment breakthrough in over 20 years. A new drug combination keeps 80% of patients disease-free two years after treatment, compared to 66% with standard chemotherapy.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.
For decades, half of bladder cancer patients were too sick for standard treatment before surgery. A groundbreaking trial just gave them a powerful new option that eliminates tumors in over half of cases.
A revolutionary bladder cancer procedure at New Cross Hospital lets patients walk out the same day after just 40 minutes of treatment. Nick Weaver, 74, was cancer-free and home within hours instead of facing surgery and lengthy recovery.
A common medication for overactive bladder reduced hot flashes by nearly seven per day in men undergoing prostate cancer treatment. The discovery offers new hope for thousands struggling with this debilitating side effect.
Men undergoing hormone therapy for prostate cancer now have a surprising new option to fight debilitating hot flashes: a common bladder medication. A national clinical trial found the drug reduced hot flashes dramatically while improving quality of life.
Scientists at Purdue University created an mRNA cancer therapy that works like a freeze-dried powder, solving a huge storage problem that has held back other treatments. The breakthrough could make advanced bladder cancer treatments accessible to hospitals everywhere.
A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials. The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.
Ghana announced major funding initiatives to make breast cancer treatment more affordable and accessible for all citizens. The Ministry of Health brought together leaders to create practical solutions for reducing the crushing financial burden cancer patients face.
A Brighton breast cancer survivor is breaking the silence around cancer by sharing her story and encouraging open conversations. Her early detection and connection with other survivors shows the power of awareness and community support.
After surviving breast cancer, Prisca Githuka founded Pink Hearts Cancer Support Foundation to help others navigate their own cancer journeys. On World Cancer Day, she's sharing her story to prove that a cancer diagnosis doesn't have to be the end.
A new AI-powered test that predicts bladder cancer outcomes just earned FDA breakthrough status, bringing precision medicine to thousands who've never had access before. The technology reads standard pathology slides to help doctors match treatment intensity to each patient's actual risk.
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
Every single patient in a groundbreaking bowel cancer trial remains cancer-free nearly three years after treatment, flipping the script on standard care. The experimental immunotherapy worked so well that more than half showed no cancer by surgery.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
When Caitlin Koehler was diagnosed with an extremely rare ovarian cancer at 27, she trusted MD Anderson's expert team to create a personalized treatment plan. Now cancer-free after beating two recurrences, she's proof that specialized care makes all the difference for young adults facing rare diagnoses.
Showing 20 of 3357